A detailed history of Black Rock Inc. transactions in Deciphera Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,994,276 shares of DCPH stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,994,276
Previous 5,976,266 0.3%
Holding current value
$0
Previous $96.4 Million 2.19%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$13.58 - $17.36 $244,575 - $312,653
18,010 Added 0.3%
5,994,276 $94.3 Million
Q4 2023

Feb 13, 2024

BUY
$10.11 - $16.54 $5.33 Million - $8.72 Million
527,260 Added 9.68%
5,976,266 $96.4 Million
Q3 2023

Nov 13, 2023

SELL
$12.46 - $15.48 $236,652 - $294,011
-18,993 Reduced 0.35%
5,449,006 $69.3 Million
Q2 2023

Aug 11, 2023

SELL
$13.28 - $15.96 $1.02 Million - $1.23 Million
-76,989 Reduced 1.39%
5,467,999 $77 Million
Q1 2023

May 12, 2023

BUY
$14.26 - $22.1 $1.78 Million - $2.76 Million
124,963 Added 2.31%
5,544,988 $85.7 Million
Q4 2022

Feb 13, 2023

BUY
$14.85 - $19.04 $3.09 Million - $3.96 Million
208,162 Added 3.99%
5,420,025 $88.8 Million
Q3 2022

Nov 14, 2022

SELL
$12.38 - $20.23 $3.92 Million - $6.41 Million
-316,879 Reduced 5.73%
5,211,863 $96.4 Million
Q2 2022

Aug 12, 2022

BUY
$9.11 - $13.98 $6.23 Million - $9.55 Million
683,366 Added 14.1%
5,528,742 $72.7 Million
Q1 2022

May 12, 2022

BUY
$6.87 - $11.11 $7.2 Million - $11.6 Million
1,047,807 Added 27.59%
4,845,376 $44.9 Million
Q4 2021

Feb 10, 2022

BUY
$7.7 - $37.13 $790,512 - $3.81 Million
102,664 Added 2.78%
3,797,569 $37.1 Million
Q3 2021

Nov 09, 2021

BUY
$26.46 - $37.15 $362,290 - $508,657
13,692 Added 0.37%
3,694,905 $126 Million
Q2 2021

Aug 11, 2021

BUY
$32.73 - $47.95 $120 Million - $177 Million
3,681,213 New
3,681,213 $135 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.